Developer docs
API playgroundTry for free, no card

Search company profiles

Lapsi Health

Full company profile

uuid0000uz4

Namestring
Lapsi Health
Websiteurl
lapsihealth.com
Company typeenum
Private
Founded yearint
2021
Short descriptiontext

Lapsi Health is a Dutch medical technology company that develops the FDA-cleared Keikku 2.0 digital stethoscope and AI-powered clinical platform (Scribe, Reference) for healthcare providers, automating auscultation, documentation, and diagnostic support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmsterdam, Netherlands
HQ citystring
Amsterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital stethoscope devices, AI clinical documentation, clinical decision support, medical sound analytics, cardiac auscultation AI
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALABAD
Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLACANAE
SaMD – Monitoring, Triage & Risk Stratification Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Prepackaged Software7372
Product category
Digital Health Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales (Keikku Device)
TypeHardware Sales
Description

Sale of FDA-cleared Keikku 2.0 digital stethoscope hardware to healthcare providers and institutions. The device serves as the hardware foundation for the AI-powered clinical platform.

prnewswire.co.uk
2Software Subscriptions (Scribe & Reference)
TypeSubscription Recurring
Description

Subscription-based access to AI-powered clinical documentation (Scribe) and clinical reference (Reference) modules. The platform offers a freemium entry point with premium enterprise tiers.

keikku.health
3Enterprise Platform Licensing
TypeSubscription Recurring
Description

Enterprise tier offerings providing comprehensive access to the clinical AI platform for larger healthcare organizations, including dedicated support and advanced features.

keikku.health
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details2 tiers
1Free tier - Get Keikku free
ModelFreemiumBilling cadenceMonthly
Notes

Freemium entry point allowing clinicians to access basic platform features at no cost. This enables product-led growth and adoption.

keikku.health
2Enterprise tier - Get Keikku free (Enterprise)
ModelSubscriptionBilling cadenceAnnual
Notes

Enterprise tier for larger healthcare organizations with dedicated features and support. Requires contact for pricing details.

keikku.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Keikku
Description

FDA-cleared digital stethoscope with integrated AI capabilities, including Scribe (AI documentation), Reference (clinical question answering), and hardware components. Keikku 2.0 is the latest version launched in October 2025.

keikku.health
Core offering1 text field

Lapsi Health develops the Keikku clinical AI platform, an FDA-cleared ecosystem that pairs a digital stethoscope device with AI-powered software modules—Keikku Scribe for voice-activated clinical documentation and Keikku Reference for cited clinical question answering—plus integrated eMurmur cardiac AI for diagnostic support. The platform converts physician–patient conversations into structured notes, retrieves evidence-based clinical answers, and captures body sounds for auscultation and digital biomarker analysis during consultations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • FDA 510(k) clearance achieved for Keikku 2.0 digital stethoscope
+1 more record
Product overview1 text field

Lapsi Health offers Keikku, a unified FDA-cleared clinical AI platform designed for medical consultations. The platform comprises hardware (the Keikku digital stethoscope device) and software modules (Scribe and Reference) that work independently or together as an integrated ecosystem. Keikku 2.0 represents the flagship product combining FDA-cleared stethoscope hardware with built-in AI Scribe capabilities for real-time auscultation, clinical documentation, and diagnostic support. The platform is designed to improve clinical efficiency and patient care by automating documentation and providing cited clinical references.

Product and service3 records
1Keikku 2.0 Digital Stethoscope
CategoryClinical AI hardware
Description

FDA 510(k)-cleared voice-activated digital stethoscope hardware that captures body sounds for real-time auscultation, integrates AI-powered documentation, and supports diagnostic workflows for clinicians and healthcare institutions.

2Keikku Scribe
CategoryClinical AI software module
Description

AI-powered clinical documentation module that converts physician–patient conversations into structured medical notes automatically, reducing typing and administrative burden for clinicians.

3Keikku Reference
CategoryClinical AI software module
Description

Clinical decision support module that answers clinical questions with cited answers in seconds from trusted medical sources, supporting evidence-based decision-making during consultations.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-11
Description

Lapsi Health and eMurmur announced a strategic partnership to integrate eMurmur's AI algorithms into Lapsi Health's Keikku 2.0 FDA-cleared digital stethoscope. The integration combines eMurmur's cardiac AI algorithms with Keikku 2.0's hardware to enhance cardiac auscultation and documentation. This integration is expected to improve clinical diagnostics and efficiency across various healthcare settings, providing enhanced cardiac diagnostic accuracy through AI-powered analysis.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Suki offers an AI voice assistant for clinicians that generates notes and answers clinical questions, closely overlapping with both Keikku Scribe and Reference. Suki is venture-backed and deployed across US health systems, making it a direct comparable in functionality and target buyer.

TypeDirect peer
Description

Eko Health is the most direct competitor to Lapsi — both make digital stethoscopes enhanced with FDA-cleared AI algorithms (notably cardiac AI for murmur and AFib detection). Eko has a larger installed base in US health systems and pulmonology/cardiology workflows, making it the closest comparable in product, customer, and regulatory positioning.

TypeBroad incumbent
Description

Augmedix provides AI-assisted and human-in-the-loop clinical documentation services to US health systems. While not a hardware player, it competes for the same documentation budget and EHR-integrated scribe workflows that Keikku Scribe targets, making it a broader incumbent in adjacent clinical documentation.

TypeEmerging player
Description

Nabla offers an ambient AI medical scribe that produces clinical notes from patient encounters, directly overlapping with Keikku Scribe. It is venture-backed with US/EU deployment, making it an emerging competitor in the same clinical AI documentation category Lapsi is pursuing.

TypeBroad incumbent
Description

Microsoft's Nuance DAX Copilot is an ambient AI scribe deeply integrated with Epic and other EHRs, and is one of the largest deployed clinical documentation AI products. It competes head-on with Keikku Scribe and Reference inside health systems, and benefits from Microsoft/Azure distribution and capital scale that Lapsi cannot match.

TypeEmerging player
Description

Thinklabs makes a digital stethoscope focused on high-fidelity sound capture for auscultation and telehealth. It overlaps with Lapsi on the digital stethoscope hardware layer but lacks an integrated AI scribe offering, making it a partial / emerging competitor in the same niche.

TypeEmerging player
Description

Sonavi Labs develops AI-enabled digital stethoscopes with respiratory/pulmonary diagnostic algorithms (e.g., pneumonia detection). It is comparable to Lapsi on the hardware-plus-AI-auscultation axis and competes for similar clinical use cases in primary care and global health.

TypeBroad incumbent
Description

3M Littmann (now Solventum) is the dominant traditional stethoscope brand with deep penetration across clinicians globally. While it does not currently bundle AI scribes, its installed base, brand trust, and clinical relationships represent the incumbent landscape Lapsi must displace — and a likely acquisition/partnership candidate for the Keikku hardware story.

TypeDirect peer
Description

Abridge is a leading AI medical scribe that converts clinician-patient conversations into structured notes, directly overlapping with Keikku Scribe. Abridge is well-funded, widely deployed in US health systems, and competes for the same clinical documentation budget that Lapsi targets — albeit without hardware.

TypeEmerging player
Description

Steth IO produces a smartphone-based digital stethoscope with AI auscultation capabilities, competing in the same low-cost, software-driven digital stethoscope niche as Keikku Hardware. It is a relevant emerging player, particularly for price-sensitive and telehealth use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lapsi Health

Digital Health Medical Deviceslapsihealth.com

Lapsi Health is a Dutch medical technology company that develops the FDA-cleared Keikku 2.0 digital stethoscope and AI-powered clinical platform (Scribe, Reference) for healthcare providers, automating auscultation, documentation, and diagnostic support.

Lapsi Health firmographics

Firmographics
Name
Lapsi Health
Website
https://lapsihealth.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Lapsi Health is a Dutch medical technology company that develops the FDA-cleared Keikku 2.0 digital stethoscope and AI-powered clinical platform (Scribe, Reference) for healthcare providers, automating auscultation, documentation, and diagnostic support.
Ownership category
akta.pro rank

Lapsi Health industry classification

Industry
Product category
Digital Health Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALABAD
Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLACANAE
SaMD – Monitoring, Triage & Risk Stratification Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital stethoscope devices
  • AI clinical documentation
  • Clinical decision support
  • Medical sound analytics
  • Cardiac auscultation AI

Where Lapsi Health is headquartered

Location

Headquarters

HQ city
Amsterdam
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

Lapsi Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Hardware Sales (Keikku Device): Sale of FDA-cleared Keikku 2.0 digital stethoscope hardware to healthcare providers and institutions. The device serves as the hardware foundation for the AI-powered clinical platform.
  2. Software Subscriptions (Scribe & Reference): Subscription-based access to AI-powered clinical documentation (Scribe) and clinical reference (Reference) modules. The platform offers a freemium entry point with premium enterprise tiers.
  3. Enterprise Platform Licensing: Enterprise tier offerings providing comprehensive access to the clinical AI platform for larger healthcare organizations, including dedicated support and advanced features.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree tier - Get Keikku free
SubscriptionAnnualEnterprise tier - Get Keikku free (Enterprise)

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Lapsi Health product offering

Product offering

Core offering

Lapsi Health develops the Keikku clinical AI platform, an FDA-cleared ecosystem that pairs a digital stethoscope device with AI-powered software modules—Keikku Scribe for voice-activated clinical documentation and Keikku Reference for cited clinical question answering—plus integrated eMurmur cardiac AI for diagnostic support. The platform converts physician–patient conversations into structured notes, retrieves evidence-based clinical answers, and captures body sounds for auscultation and digital biomarker analysis during consultations.

Product overview

Lapsi Health offers Keikku, a unified FDA-cleared clinical AI platform designed for medical consultations. The platform comprises hardware (the Keikku digital stethoscope device) and software modules (Scribe and Reference) that work independently or together as an integrated ecosystem. Keikku 2.0 represents the flagship product combining FDA-cleared stethoscope hardware with built-in AI Scribe capabilities for real-time auscultation, clinical documentation, and diagnostic support. The platform is designed to improve clinical efficiency and patient care by automating documentation and providing cited clinical references.

Differentiator

Problem solved

Functional benefit

Brands

  • Keikku: FDA-cleared digital stethoscope with integrated AI capabilities, including Scribe (AI documentation), Reference (clinical question answering), and hardware components. Keikku 2.0 is the latest version launched in October 2025.

Products and services

  • Keikku 2.0 Digital Stethoscope FDA 510(k)-cleared voice-activated digital stethoscope hardware that captures body sounds for real-time auscultation, integrates AI-powered documentation, and supports diagnostic workflows for clinicians and healthcare institutions.
  • Keikku Scribe AI-powered clinical documentation module that converts physician–patient conversations into structured medical notes automatically, reducing typing and administrative burden for clinicians.
  • Keikku Reference Clinical decision support module that answers clinical questions with cited answers in seconds from trusted medical sources, supporting evidence-based decision-making during consultations.

Quantifiable outcome

  • FDA 510(k) clearance achieved for Keikku 2.0 digital stethoscope
  • +1 more outcomes

Companies that use Lapsi Health

Customer profile

Segments1 record

Ideal customer profiles2 records

Lapsi Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature5 records

Lapsi Health partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • eMurmurcoreTechnology or Integration · 11 November 2025Lapsi Health and eMurmur announced a strategic partnership to integrate eMurmur's AI algorithms into Lapsi Health's Keikku 2.0 FDA-cleared digital stethoscope. The integration combines eMurmur's cardiac AI algorithms with Keikku 2.0's hardware to enhance cardiac auscultation and documentation. This integration is expected to improve clinical diagnostics and efficiency across various healthcare settings, providing enhanced cardiac diagnostic accuracy through AI-powered analysis.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Lapsi Health competitors and assessment

Company assessment

Direct peers

  • Suki AI: Suki offers an AI voice assistant for clinicians that generates notes and answers clinical questions, closely overlapping with both Keikku Scribe and Reference. Suki is venture-backed and deployed across US health systems, making it a direct comparable in functionality and target buyer.
  • Eko Health: Eko Health is the most direct competitor to Lapsi — both make digital stethoscopes enhanced with FDA-cleared AI algorithms (notably cardiac AI for murmur and AFib detection). Eko has a larger installed base in US health systems and pulmonology/cardiology workflows, making it the closest comparable in product, customer, and regulatory positioning.
  • Abridge: Abridge is a leading AI medical scribe that converts clinician-patient conversations into structured notes, directly overlapping with Keikku Scribe. Abridge is well-funded, widely deployed in US health systems, and competes for the same clinical documentation budget that Lapsi targets — albeit without hardware.

Broad incumbents

  • Augmedix: Augmedix provides AI-assisted and human-in-the-loop clinical documentation services to US health systems. While not a hardware player, it competes for the same documentation budget and EHR-integrated scribe workflows that Keikku Scribe targets, making it a broader incumbent in adjacent clinical documentation.
  • Nuance (Microsoft DAX Copilot): Microsoft's Nuance DAX Copilot is an ambient AI scribe deeply integrated with Epic and other EHRs, and is one of the largest deployed clinical documentation AI products. It competes head-on with Keikku Scribe and Reference inside health systems, and benefits from Microsoft/Azure distribution and capital scale that Lapsi cannot match.
  • 3M Littmann (Solventum): 3M Littmann (now Solventum) is the dominant traditional stethoscope brand with deep penetration across clinicians globally. While it does not currently bundle AI scribes, its installed base, brand trust, and clinical relationships represent the incumbent landscape Lapsi must displace — and a likely acquisition/partnership candidate for the Keikku hardware story.

Emerging players

  • Nabla: Nabla offers an ambient AI medical scribe that produces clinical notes from patient encounters, directly overlapping with Keikku Scribe. It is venture-backed with US/EU deployment, making it an emerging competitor in the same clinical AI documentation category Lapsi is pursuing.
  • Thinklabs One: Thinklabs makes a digital stethoscope focused on high-fidelity sound capture for auscultation and telehealth. It overlaps with Lapsi on the digital stethoscope hardware layer but lacks an integrated AI scribe offering, making it a partial / emerging competitor in the same niche.
  • Sonavi Labs: Sonavi Labs develops AI-enabled digital stethoscopes with respiratory/pulmonary diagnostic algorithms (e.g., pneumonia detection). It is comparable to Lapsi on the hardware-plus-AI-auscultation axis and competes for similar clinical use cases in primary care and global health.
  • Steth IO (Eko alternative): Steth IO produces a smartphone-based digital stethoscope with AI auscultation capabilities, competing in the same low-cost, software-driven digital stethoscope niche as Keikku Hardware. It is a relevant emerging player, particularly for price-sensitive and telehealth use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Lapsi Health social profiles

Digital presence

Lapsi Health compliance and trust

Trust signal

Compliance2 records

Lapsi Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lapsi Health leadership team

Management profile

Number of profiles

Profiles7 records

Lapsi Health funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lapsi Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lapsi Health

What does Lapsi Health do?

Lapsi Health develops the Keikku clinical AI platform, an FDA-cleared ecosystem that pairs a digital stethoscope device with AI-powered software modules—Keikku Scribe for voice-activated clinical documentation and Keikku Reference for cited clinical question answering—plus integrated eMurmur cardiac AI for diagnostic support. The platform converts physician–patient conversations into structured notes, retrieves evidence-based clinical answers, and captures body sounds for auscultation and digital biomarker analysis during consultations.

Is Lapsi Health a public or private company?

Lapsi Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Lapsi Health founded?

Lapsi Health was founded in 2021. It employs 11 to 50 people.

Where is Lapsi Health based?

Lapsi Health is headquartered in Amsterdam, Netherlands, in the Europe region.

How does Lapsi Health make money?

Three revenue lines are on record. Hardware Sales (Keikku Device) is the primary driver. The others are software Subscriptions (Scribe & Reference) and enterprise Platform Licensing.

Who are Lapsi Health's main competitors?

Direct peers on record are Suki AI, Eko Health and Abridge. Broad incumbents are Augmedix, Nuance (Microsoft DAX Copilot) and 3M Littmann (Solventum). Emerging players are Nabla, Thinklabs One, Sonavi Labs and Steth IO (Eko alternative).

Does Lapsi Health have an API?

No public API is recorded for Lapsi Health.

What industry is Lapsi Health in?

Lapsi Health's product category is Digital Health Medical Devices. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLALABAD, Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AktienFormer Philips Latin America CEO Fabia Tetteroo-Bueno Joins Lapsi Health / Keikku Board to Lead Latin American ExpansionFabia Tetteroo-Bueno, former Philips Latin America CEO, joined Lapsi Health's board to lead Keikku's Latin American expansion. She will guide strategy and partnerships, following Keikku's moves in Santiago and collaborations with SMC and SOMEIC.PR NewswireFormer Philips Latin America CEO Fabia Tetteroo-Bueno Joins Lapsi Health / Keikku Board to Lead Latin American ExpansionFabia Tetteroo-Bueno, former Philips Latin America CEO, joined Lapsi Health's board to lead Keikku's Latin American expansion. She will guide strategy and partnerships, following Keikku's office in Santiago and collaborations with SMC and SOMEIC. Keikku offers ambient AI and clinical decision support for Spanish- and Portuguese-speaking clinicians.FinancialContent Business PageLapsi Health and the Mexican Society of Cardiology Announce Strategic Collaboration to Expand Access to Cardiovascular Clinical Guidance Through KeikkuLapsi Health and the Mexican Society of Cardiology announced a collaboration to integrate SMC clinical guidelines into Keikku Reference, an AI clinical platform. SMC members receive a 15% discount on Keikku subscriptions, and Lapsi will contribute 10% of subscription revenue to support SMC's mission. The partnership aims to expand AI adoption in cardiovascular medicine in Latin America.Business Wire BlogLapsi Health and the Mexican Society of Cardiology Announce Strategic Collaboration to Expand Access to Cardiovascular Clinical Guidance Through KeikkuLapsi Health and the Mexican Society of Cardiology announced a collaboration to integrate SMC clinical guidelines into Keikku Reference, expanding access to AI-powered cardiovascular guidance. SMC members receive a 15% discount on Keikku subscriptions, and Lapsi will contribute 10% of subscription revenue to support the Society's mission.HIT ConsultantLapsi Health Partners with Redox to Integrate Keikku Clinical AI Platform Directly Into EHR InfrastructureDutch-American clinical AI developer Lapsi Health has partnered with healthcare data interoperability leader Redox to natively integrate Lapsi's Keikku Clinical AI Platform into Electronic Health Record environments. The Keikku platform, which provides ambient clinical documentation, real-time contextual references, and diagnostic support, will leverage Redox's Connection Network spanning over 12,000 healthcare organizations and 100+ EHR systems including Epic, Oracle Health/Cerner, and MEDITECH. The integration replaces manual point-to-point interface builds with a scalable data infrastructure layer, reducing implementation cycles from months to weeks and eliminating workflow friction for clinicians.AijournRedox and Lapsi Health Collaborate to Bring Industry-Leading AI-Powered Tools Directly Into EHR WorkflowsRedox and Lapsi Health announced a collaboration to integrate Lapsi Health's Keikku AI clinical platform directly into existing electronic health record (EHR) systems through Redox's interoperability network, which spans over 12,000 healthcare organizations and more than 100 EHRs. The partnership aims to address workflow fragmentation that has hindered AI adoption in healthcare by enabling clinicians to access AI-powered documentation, clinical reference, and diagnostic support without leaving their existing systems. Redox serves as the data infrastructure layer for Keikku, providing a pathway to scale deployment across health systems without requiring lengthy custom integrations.PR NewswireRedox and Lapsi Health Collaborate to Bring Industry-Leading AI-Powered Tools Directly Into EHR WorkflowsRedox and Lapsi Health announced a collaboration to integrate Keikku's AI clinical platform into existing EHRs via Redox's Connection Network, which spans over 12,000 healthcare organizations. The partnership aims to reduce integration complexity and accelerate AI adoption in clinical workflows.PR NewswireLapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0Lapsi Health and eMurmur announced a partnership to integrate eMurmur's cardiac AI algorithms into Keikku 2.0, the world's first FDA-cleared smart stethoscope. The integration combines eMurmur's FDA-cleared murmur detection (90% sensitivity and specificity) with Keikku's AI scribe, available via software update. The partnership aims to deliver cardiologist-level auscultation insights across specialties.NewswireLapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0Lapsi Health and eMurmur announced a partnership to integrate eMurmur's FDA-cleared cardiac murmur detection AI algorithms into Keikku 2.0, the world's first FDA-cleared smart stethoscope with an integrated AI scribe. The combined platform delivers 90% sensitivity and specificity in detecting abnormal heart murmurs alongside AI-driven transcription, enabling physician-level cardiac auscultation with simultaneous patient documentation. The integrated solution will be deployed to Keikku 2.0 users via a software update with no additional hardware required.